K. Jurianz

653 total citations
10 papers, 469 citations indexed

About

K. Jurianz is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, K. Jurianz has authored 10 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 3 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Oncology. Recurrent topics in K. Jurianz's work include Immunotherapy and Immune Responses (4 papers), Complement system in diseases (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). K. Jurianz is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Complement system in diseases (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). K. Jurianz collaborates with scholars based in Germany and Israel. K. Jurianz's co-authors include Michael Kirschfink, Zvi Fishelson, Helena Garcia Schüler, Stefanie Ziegler, Natalie Donin, Osnat Bohana‐Kashtan, Sarah Kraus, Lea Ziporen, Volker Schirrmacher and Yoram Reiter and has published in prestigious journals such as International Journal of Cancer, Clinical & Experimental Immunology and Molecular Immunology.

In The Last Decade

K. Jurianz

10 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K. Jurianz Germany	8	312	130	103	81	62	10	469
V Duprez France	15	408 1.3×	197 1.5×	98 1.0×	141 1.7×	92 1.5×	26	660
Robert R. Getty United States	8	247 0.8×	165 1.3×	55 0.5×	51 0.6×	69 1.1×	8	442
Jean Decker United States	6	254 0.8×	124 1.0×	94 0.9×	95 1.2×	19 0.3×	9	389
Marie‐Claire Devilder France	12	360 1.2×	146 1.1×	40 0.4×	112 1.4×	47 0.8×	21	544
G. Nagel Germany	11	276 0.9×	173 1.3×	171 1.7×	138 1.7×	60 1.0×	13	597
M T Maunoury France	15	505 1.6×	152 1.2×	85 0.8×	306 3.8×	88 1.4×	18	762
Takehiko Tachibana Japan	12	164 0.5×	172 1.3×	96 0.9×	115 1.4×	47 0.8×	48	401
T Nakagawa Japan	10	427 1.4×	82 0.6×	151 1.5×	80 1.0×	29 0.5×	14	576
K Jacobsen Canada	11	353 1.1×	184 1.4×	35 0.3×	132 1.6×	35 0.6×	15	603
Erik Lundgren Sweden	12	246 0.8×	137 1.1×	54 0.5×	330 4.1×	44 0.7×	24	617

Countries citing papers authored by K. Jurianz

Since Specialization

Citations

This map shows the geographic impact of K. Jurianz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Jurianz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Jurianz more than expected).

Fields of papers citing papers by K. Jurianz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Jurianz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Jurianz. The network helps show where K. Jurianz may publish in the future.

Co-authorship network of co-authors of K. Jurianz

This figure shows the co-authorship network connecting the top 25 collaborators of K. Jurianz. A scholar is included among the top collaborators of K. Jurianz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Jurianz. K. Jurianz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Donin, Natalie, et al.. (2003). Complement resistance of human carcinoma cells depends on membrane regulatory proteins, protein kinases and sialic acid. Clinical & Experimental Immunology. 131(2). 254–263. 120 indexed citations

Jurianz, K., Stefanie Ziegler, Natalie Donin, et al.. (2001). K562 erythroleukemic cells are equipped with multiple mechanisms of resistance to lysis by complement. International Journal of Cancer. 93(6). 848–854. 49 indexed citations

Jurianz, K., et al.. (1999). Neutralization of complement regulatory proteins augments lysis of breast carcinoma cells targeted with rhumAb anti-HER2. Immunopharmacology. 42(1-3). 209–218. 54 indexed citations

Jurianz, K., Stefanie Ziegler, Helena Garcia Schüler, et al.. (1999). Complement resistance of tumor cells: basal and induced mechanisms. Molecular Immunology. 36(13-14). 929–939. 173 indexed citations

Jurianz, K., Paul von Hoegen, & Volker Schirrmacher. (1999). Immunological and molecular characterization of an aggressive murine lymphoma variant: modulation in vitro and in vivo.. International Journal of Oncology. 15(1). 71–9. 2 indexed citations

Schirrmacher, Volker, et al.. (1999). Tumor stimulator cell modification by infection with Newcastle Disease Virus: analysis of effects and mechanism in MLTC-CML cultures.. International Journal of Oncology. 14(2). 205–15. 17 indexed citations

Jurianz, K., Paul von Hoegen, & Volker Schirrmacher. (1998). Superiority of the ear pinna over a subcutaneous tumour inoculation site for induction of a Th1-type cytokine response. Cancer Immunology Immunotherapy. 45(6). 327–333. 10 indexed citations

Schirrmacher, Volker, et al.. (1997). Intra-pinna induction of specific antitumor immune T cell functions. International Journal of Oncology. 11(2). 227–33. 4 indexed citations

Jurianz, K., C Haas, Marcus Hubbe, et al.. (1995). ADHESIVE FUNCTION OF NEWCASTLE-DISEASE VIRUS HEMAGGLUTININ IN TUMOR-HOST INTERACTION. International Journal of Oncology. 7(3). 539–545. 10 indexed citations

10.

Schirrmacher, Volker, Philipp Beckhove, Achim Krüger, et al.. (1995). EFFECTIVE IMMUNE REJECTION OF ADVANCED METASTASIZED CANCER. International Journal of Oncology. 6(3). 505–21. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact